Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. F. Andersen · SciRah

Researcher profile · Semantic Scholar

N. F. Andersen

Share profile

N. F. Andersen — researcher profile on SciRah

h-index: 21
Works: 82
Citations: 1,748

Most-cited papers

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 stud
M. Cavo, F. Gay, M. Beksaç, L. Pantani +56 more
2020The Lancet Haematology255 citations Open access
Semantic Scholar
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial.
U. Mellqvist, P. Gimsing, O. Hjertner, S. Lenhoff +21 more
2013Blood143 citations Open access
Semantic Scholar
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
P. Gimsing, K. Carlson, I. Turesson, P. Fayers +18 more
2010The Lancet Oncology121 citations Open access
Semantic Scholar
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
M. Went, A. Sud, A. Försti, Britta Halvarsson +127 more
2018Nature Communications108 citations Open access
Semantic Scholar
Syndecan‐1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival
N. F. Andersen, T. Standal, J. L. Nielsen, L. Heickendorff +3 more
2005British Journal of Haematology94 citations
Semantic Scholar
Monocyte/macrophage‐derived soluble CD163: a novel biomarker in multiple myeloma
M. Andersen, N. Abildgaard, M. Maniecki, H. Møller +1 more
2014European Journal of Haematology64 citations
Semantic Scholar
Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study
R. Sørrig, T. Klausen, M. Salomo, A. Vangsted +10 more
2016European Journal of Haematology63 citations Open access
Semantic Scholar
Causes of early death in multiple myeloma patients who are ineligible for high‐dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database
M. Holmström, P. Gimsing, N. Abildgaard, N. F. Andersen +12 more
2015American journal of hematology/oncology62 citations Open access
Semantic Scholar
The Danish National Multiple Myeloma Registry
P. Gimsing, M. Holmström, T. Klausen, N. F. Andersen +10 more
2016Clinical Epidemiology58 citations Open access
Semantic Scholar
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
M. Hjorth, O. Hjertner, L. Knudsen, N. Gulbrandsen +15 more
2012European Journal of Haematology49 citations Open access
Semantic Scholar
The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
M. Andersen, N. F. Andersen, S. Rødgaard-Hansen, M. Hokland +2 more
2015Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis48 citations
Semantic Scholar
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
H. Gregersen, A. Vangsted, N. Abildgaard, N. F. Andersen +7 more
2017Cancer Medicine47 citations Open access
Semantic Scholar
Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
T. Clemmensen, J. Soerensen, N. H. Hansson, L. Tolbod +6 more
2018Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease43 citations Open access
Semantic Scholar
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials
T. Klausen, H. Gregersen, N. Abildgaard, N. F. Andersen +4 more
2018Leukemia42 citations Open access
Semantic Scholar
Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis
T. Clemmensen, H. Mølgaard, J. Sörensen, H. Eiskjær +6 more
2017European Journal of Heart Failure40 citations Open access
Semantic Scholar
A polymorphism in NFKB1 is associated with improved effect of interferon-α maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support
A. Vangsted, T. Klausen, P. Gimsing, N. F. Andersen +3 more
2009Haematologica31 citations Open access
Semantic Scholar
Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib
A. Vangsted, T. Klausen, N. Abildgaard, N. F. Andersen +4 more
2011Annals of Hematology28 citations Open access
Semantic Scholar
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
A. Vangsted, K. Søeby, T. Klausen, N. Abildgaard +6 more
2010BMC Cancer28 citations Open access
Semantic Scholar
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
U. Mellqvist, J. Westin, P. Gimsing, O. Hjertner +22 more
200928 citations
Semantic Scholar
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma
N. F. Andersen, U. Vogel, T. Klausen, P. Gimsing +3 more
2012International Journal of Cancer27 citations
Semantic Scholar
Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial
U. H. Mellquist, P. Gimsing, O. Hjertner, S. Lenhoff +25 more
201123 citations
Semantic Scholar
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry
L. Redder, T. Klausen, A. Vangsted, H. Gregersen +12 more
2020British Journal of Haematology20 citations Open access
Semantic Scholar
Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study
M. Cavo, F. Gay, M. Beksaç, M. Dimopoulos +33 more
2020Blood20 citations Open access
Semantic Scholar
Abnormal Coronary Flow Velocity Reserve and Decreased Myocardial Contractile Reserve Are Main Factors in Relation to Physical Exercise Capacity in Cardiac Amyloidosis
T. Clemmensen, H. Eiskjær, H. Mølgaard, A. H. Larsen +5 more
2018Journal of the American Society of Echocardiography20 citations
Semantic Scholar
High serum YKL‐40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients
A. Mylin, N. Abildgaard, J. Johansen, N. F. Andersen +4 more
2008European Journal of Haematology19 citations
Semantic Scholar
Food caregivers influence on nutritional intake among admitted haematological cancer patients - a prospective study.
Astrid Lindman, Helle Rasmussen, N. F. Andersen
2013European Journal of Oncology Nursing18 citations
Semantic Scholar
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
H. Gregersen, Valdas Pečeliūnas, K. Remes, F. Schjesvold +17 more
2021European Journal of Haematology17 citations Open access
Semantic Scholar
Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma
Sarah L. Kvorning, M. Nielsen, N. F. Andersen, M. Hokland +2 more
2019European Journal of Haematology17 citations
Semantic Scholar
Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
P. Gimsing, O. Hjertner, N. Abildgaard, N. F. Andersen +8 more
2015Bone Marrow Transplantation17 citations Open access
Semantic Scholar
Serum YKL‐40 and bone marrow angiogenesis in multiple myeloma
A. Mylin, N. F. Andersen, J. Johansen, N. Abildgaard +4 more
2009International Journal of Cancer16 citations Open access
Semantic Scholar
Germline variants at SOHLH2 influence multiple myeloma risk
Laura Duran-Lozano, G. Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, Abhishek Niroula +23 more
2021Blood Cancer Journal14 citations Open access
Semantic Scholar
Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis
N. F. Andersen, I. Kristensen, B. Preiss, J. Christensen +1 more
2015European Journal of Haematology13 citations
Semantic Scholar
STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS
M. Andersen, N. F. Andersen, K. L. Lauridsen, A. Etzerodt +5 more
2021Cancer Immunology and Immunotherapy12 citations Open access
Semantic Scholar
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
H. Gregersen, T. Do, I. Kristensen, U. Frølund +6 more
2018Experimental Hematology & Oncology12 citations Open access
Semantic Scholar
The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP
A. Vangsted, T. Klausen, P. Gimsing, N. Abildgaard +4 more
2011Annals of Hematology12 citations
Semantic Scholar
Clarithromycin added to the VCD regimen causes reduced health-related quality of life in multiple myeloma patients
L. K. Nielsen, T. Klausen, I. Kristensen, U. Frølund +5 more
201811 citations Open access
Semantic Scholar
A polygenic risk score for multiple myeloma risk prediction
F. Canzian, Chiara Piredda, A. Macauda, D. Zawirska +36 more
2021European Journal of Human Genetics10 citations Open access
Semantic Scholar
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
A. Macauda, Chiara Piredda, A. Clay-Gilmour, J. Sainz +50 more
2021International Journal of Cancer10 citations Open access
Semantic Scholar
Hemodialysis Using High Cut Off Filters in Light Chain Cast Nephropathy
N. Buus, J. Rantanen, S. Krag, N. F. Andersen +1 more
2015Blood Purification10 citations
Semantic Scholar
Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival
N. F. Andersen, U. Vogel, T. Klausen, P. Gimsing +3 more
2015European Journal of Haematology8 citations Open access
Semantic Scholar
Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma
A. Vangsted, T. Klausen, P. Gimsing, N. Abildgaard +7 more
2014European Journal of Haematology8 citations
Semantic Scholar
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
A. Schmitz, R. Brøndum, H. Johnsen, U. Mellqvist +23 more
2022BMC Cancer7 citations Open access
Semantic Scholar
Vascularity in thyroid neoplasms: a methodological investigation with a view to diagnostics
K. Larsen, N. F. Andersen, F. Melsen, F. B. Sørensen
2006Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS)7 citations
Semantic Scholar
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
M. Went, A. Sud, A. Försti, Britta Halvarsson +65 more
2019Nature Communications6 citations Open access
Semantic Scholar
Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry
H. Gregersen, C. B. Larsen, A. Haglund, R. Mortensen +2 more
2013Clinical Epidemiology6 citations Open access
Semantic Scholar
A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group
H. Gregersen, Valdas Pečeliūnas, K. Remes, F. Schjesvold +16 more
2019Blood5 citations Open access
Semantic Scholar
A rare presentation of cardiac amyloid deposits isolated to intramural vessels
T. Clemmensen, H. Mølgaard, N. F. Andersen, Steen Baerentzen +2 more
2016Echocardiography4 citations
Semantic Scholar
Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma
S. Husby, M. Tulstrup, Mads Harsløf, C. Nielsen +12 more
2024Leukemia3 citations Open access
Semantic Scholar
Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)
P. Sonneveld, M. Beksaç, B. van der Holt, M. Dimopoulos +23 more
2020Blood3 citations Open access
Semantic Scholar
Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
L. Redder, T. Klausen, A. Vangsted, H. Gregersen +11 more
2019Blood3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Abildgaard×34
Invite
N. Abildgaard — researcher profile on SciRah
P. Gimsing×25
Invite
P. Gimsing — researcher profile on SciRah
H. Gregersen×25
Invite
H. Gregersen — researcher profile on SciRah
A. Vangsted×24
Invite
A. Vangsted — researcher profile on SciRah

×12

Invite

A. Waage — researcher profile on SciRah

U. Frølund×11

Invite

U. Frølund — researcher profile on SciRah

U. Mellqvist×10

Invite

U. Mellqvist — researcher profile on SciRah

C. Helleberg×10

Invite

C. Helleberg — researcher profile on SciRah

Invite

T. Klausen — researcher profile on SciRah

Invite

M. Hansson — researcher profile on SciRah

Invite

U. Vogel — researcher profile on SciRah

Invite

H. Nahi — researcher profile on SciRah